Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, interferon and immune responses, and MicroRNA in disease regulation.
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Control of glioma cell migration and invasiveness by GDF-15
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients
P02.04 * MICRORNA-MEDIATED DOWN-REGULATION OF NKG2D LIGAND EXPRESSION REDUCES GLIOMA CELL IMMUNOGENICITY